finasteride has been researched along with Insulin Resistance in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrew, R; Gray, CD; Hughes, KA; Livingstone, DE; Macfarlane, DP; Marshall, I; Minns, FC; Stewart, LH; Upreti, R; Walker, BR | 1 |
| Andrew, R; Barat, P; Di Rollo, EM; Livingstone, DE; MacFarlane, DP; Rees, GA; Rog-Zielinska, EA; Walker, BR; Weldin, BA | 1 |
| Guay, AT; Traish, AM; Zitzmann, M | 1 |
| Kaplan, SA | 1 |
| Armstrong, MJ; Davies, NP; Di Guida, R; Dunn, WB; Flintham, RB; Grinbergs, AE; Hazlehurst, JM; Hodson, L; Hughes, BA; Nikolaou, N; Oprescu, AI; Taylor, AE; Tomlinson, JW; Yu, J | 1 |
| Arias-Santiago, S; Camacho-Martínez, FM | 1 |
| Duskova, M; Hill, M; Starka, L | 1 |
| Albanes, D; Goodman, P; Hoque, A; Hsing, AW; Kristal, A; Neuhouser, ML; Parnes, HL; Platz, EA; Pollak, M; Till, C | 1 |
| Ajossa, S; Guerriero, S; Melis, GB; Orrù, M; Paoletti, AM | 1 |
| Crawford, ED; Kaplan, SA | 1 |
1 review(s) available for finasteride and Insulin Resistance
| Article | Year |
|---|---|
5α-Reductase inhibitors alter steroid metabolism and may contribute to insulin resistance, diabetes, metabolic syndrome and vascular disease: a medical hypothesis.
Topics: 5-alpha Reductase Inhibitors; Animals; Azasteroids; Diabetes Mellitus; Dutasteride; Finasteride; Glucocorticoids; Humans; Insulin Resistance; Metabolic Syndrome; Mineralocorticoids; Obesity; Vascular Diseases | 2014 |
3 trial(s) available for finasteride and Insulin Resistance
| Article | Year |
|---|---|
5α-reductase type 1 modulates insulin sensitivity in men.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adipose Tissue; Adult; Aged; Aged, 80 and over; Azasteroids; Blood Glucose; Body Composition; Double-Blind Method; Dutasteride; Finasteride; Humans; Insulin Resistance; Male; Middle Aged; Prostatic Hyperplasia; Young Adult | 2014 |
Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adipose Tissue; Adult; Carbohydrate Metabolism; Dutasteride; Finasteride; Glucose Clamp Technique; Humans; Insulin Resistance; Lipid Metabolism; Liver; Male; Membrane Proteins; Metabolome; Steroids | 2016 |
Finasteride modifies the relation between serum C-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Topics: C-Peptide; Case-Control Studies; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Finasteride; Humans; Insulin Resistance; Leptin; Male; Middle Aged; Prostatic Neoplasms; Risk Factors | 2010 |
6 other study(ies) available for finasteride and Insulin Resistance
| Article | Year |
|---|---|
5α-Reductase type 1 deficiency or inhibition predisposes to insulin resistance, hepatic steatosis, and liver fibrosis in rodents.
Topics: 5-alpha Reductase Inhibitors; Animals; Cholestenone 5 alpha-Reductase; Dietary Fats; Enzyme Assays; Fatty Liver; Finasteride; Insulin Resistance; Liver Cirrhosis; Male; Mice; Mice, Knockout; Rats; RNA, Messenger; Weight Gain | 2015 |
Re: 5α-Reductase Type 1 Modulates Insulin Sensitivity in Men.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Azasteroids; Finasteride; Humans; Insulin Resistance; Male | 2015 |
Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
Topics: 5-alpha Reductase Inhibitors; Alopecia; Dutasteride; Erectile Dysfunction; Finasteride; Humans; Insulin Resistance; Libido; Male; Osteoporosis; Prostatic Hyperplasia; Prostatic Neoplasms | 2016 |
Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Adult; Alopecia; Androstenedione; Biomarkers; Blood Glucose; Enzyme Inhibitors; Finasteride; Glycated Hemoglobin; Humans; Insulin Resistance; Lipids; Male; Severity of Illness Index; Testosterone; Time Factors; Treatment Outcome | 2010 |
The treatment of polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Cabergoline; Cardiovascular Diseases; Clomiphene; Cyproterone Acetate; Diabetes Complications; Dopamine Agonists; Ergolines; Female; Finasteride; Flutamide; Follicle Stimulating Hormone; Gonadotropins; Hirsutism; Humans; Hypoglycemic Agents; Infertility, Female; Insulin Resistance; Metformin; Mineralocorticoid Receptor Antagonists; Obesity; Ovulation Induction; Polycystic Ovary Syndrome; Risk Factors; Spironolactone; Weight Loss | 2004 |
Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aged; Aging; Dihydrotestosterone; Enzyme Inhibitors; Finasteride; Humans; Insulin; Insulin Resistance; Male; Mitochondria; Prostate; Testosterone | 2006 |